Improvements in endotoxemic syndromes using a disintegrin, rhodostomin, through integrin αvβ3-dependent pathway

J Thromb Haemost. 2011 Mar;9(3):593-602. doi: 10.1111/j.1538-7836.2010.04163.x.

Abstract

Background and objectives: Septic shock is a major cause of morbidity and mortality in intensive care units, but there is still no effective therapy for the patients. We evaluated the effects of rhodostomin (Rn), an Arg-Gly-Asp-containing snake venom disintegrin, on lipopolysaccharide (LPS)-activated phagocytes in vitro and LPS-induced endotoxemia in vivo.

Methods and results: Rn inhibited adhesion, migration, cytokine production and mitogen-activated protein kinase (MAPK) activation of macrophage induced by LPS. Flow cytometric analysis revealed that Rn specifically blocked anti-αv mAb binding to RAW264.7. Besides inhibiting MAPK activation of THP-1, Rn bound to LPS-activated THP-1 and specifically blocked anti-αvβ3 mAb binding to THP-1. Binding assays proved that integrin αvβ3 was the binding site for rhodostomin on phagocytes. Rn reversed the enhancement of fibronectin and vitronectin on LPS-induced monocyte adhesion and cytokine release. Transfection of integrin αv siRNA also inhibited LPS-induced activation of monocyte, and Rn exerted no further inhibitory effect. Furthermore, Rn significantly decreased the production of tumor necrosis factor-α (TNF-a), interleukin (IL)-6, -1β and -10 and attenuated cardiovascular dysfunction, including blood pressure and heart pulse, and thrombocytopenia in LPS-induced endotoxemic mice. Rn also protected against tissue inflammation as evidenced by histological examination.

Conclusions: Rn may interact with αvβ3 integrin of monocytes/macrophages leading to interfere with the activation of phagocytes triggered by LPS. These results suggest that the protective function of Rn in LPS-induced endotoxemia may be attributed to its anti-inflammation activities in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cell Adhesion / drug effects
  • Cell Line
  • Cell Movement / drug effects
  • Cytokines / biosynthesis
  • Disintegrins / pharmacology
  • Endotoxemia / drug therapy*
  • Endotoxemia / physiopathology*
  • Humans
  • Integrin alphaVbeta3 / antagonists & inhibitors
  • Integrin alphaVbeta3 / genetics
  • Integrin alphaVbeta3 / physiology*
  • Lipopolysaccharides / toxicity
  • MAP Kinase Signaling System / drug effects
  • Macrophage Activation / drug effects
  • Macrophage Activation / physiology
  • Male
  • Mice
  • Mice, Inbred ICR
  • Peptides / pharmacology*
  • Phagocytes / drug effects
  • Phagocytes / physiology
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Thrombocytopenia / blood
  • Thrombocytopenia / drug therapy

Substances

  • Cytokines
  • Disintegrins
  • Integrin alphaVbeta3
  • Lipopolysaccharides
  • Peptides
  • RNA, Small Interfering
  • rhodostomin